Piramal Life Sciences , was in the news last year for selling Piramal Healthcare's domestic formulations business to Abbott Laboratories for $3.72 billion. Later, the firm also sold its diagnostic services business to Super Religare Laboratories -- owned...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 2-India's Piramal Healthcare to enter fin services sector
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account